Abbott Laboratories 2013 Annual Report Download - page 32

Download and view the complete annual report

Please find page 32 of the 2013 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 76

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76

30
ABBOTT 2013 ANNUAL REPORT
30
KEY MARKET TRENDS
• Aging global populations
• Increasing emphasis on the use of in vitro testing in
diagnosis and disease prevention
• Increased reliance on point-of-care testing
• Growth in personalized medicine driving increased
use of genetic tests to determine suitability for
certain treatments
• Market demand for improved laboratory eciency
• Emerging market investments in
healthcare infrastructure
2013 BUSINESS HIGHLIGHTS
• Balanced growth in developed and emerging markets
• Helped labs around the world manage vast amounts of
data by providing sophisticated automation and
information management capabilities
• Launched 17 new assays across a variety of disease states
• Several next-generation systems currently in development
• Gene-based tests in development to determine
suitability for targeted therapies
DIAGNOSTICS
DIAGNOSTICS